- Home
- CYRX vs ORGO Comparison
CYRX vs ORGO Comparison
Compare CYRX & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYRX
- ORGO
- Stock Information
- Founded
- CYRX 1999
- ORGO 1985
- Country
- CYRX United States
- ORGO United States
- Employees
- CYRX N/A
- ORGO N/A
- Industry
- CYRX Biotechnology: Pharmaceutical Preparations
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- CYRX Health Care
- ORGO Health Care
- Exchange
- CYRX Nasdaq
- ORGO Nasdaq
- Market Cap
- CYRX 422.6M
- ORGO 418.7M
- IPO Year
- CYRX N/A
- ORGO N/A
- Fundamental
- Price
- CYRX $8.16
- ORGO $3.53
- Analyst Decision
- CYRX Buy
- ORGO Strong Buy
- Analyst Count
- CYRX 7
- ORGO 2
- Target Price
- CYRX $13.14
- ORGO $5.00
- AVG Volume (30 Days)
- CYRX 261.6K
- ORGO 559.3K
- Earning Date
- CYRX 03-11-2025
- ORGO 02-27-2025
- Dividend Yield
- CYRX N/A
- ORGO N/A
- EPS Growth
- CYRX N/A
- ORGO N/A
- EPS
- CYRX N/A
- ORGO N/A
- Revenue
- CYRX $226,113,000.00
- ORGO $455,038,000.00
- Revenue This Year
- CYRX N/A
- ORGO $9.65
- Revenue Next Year
- CYRX $7.70
- ORGO $1.57
- P/E Ratio
- CYRX N/A
- ORGO N/A
- Revenue Growth
- CYRX N/A
- ORGO 1.34
- 52 Week Low
- CYRX $5.32
- ORGO $2.17
- 52 Week High
- CYRX $20.11
- ORGO $4.57
- Technical
- Relative Strength Index (RSI)
- CYRX 53.74
- ORGO 59.20
- Support Level
- CYRX $6.97
- ORGO $2.88
- Resistance Level
- CYRX $8.97
- ORGO $3.24
- Average True Range (ATR)
- CYRX 0.55
- ORGO 0.16
- MACD
- CYRX -0.08
- ORGO 0.06
- Stochastic Oscillator
- CYRX 59.50
- ORGO 97.04
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.